MA, S., SR, C., SL, G., & S, P. (2013). Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions. Dove Medical Press.
Cita Chicago Style (17a ed.)MA, Singer, Cohen SR, Groth SL, y Porbandarwalla S. Comparing Bevacizumab and Ranibizumab for Initial Reduction of Central Macular Thickness in Patients with Retinal Vein Occlusions. Dove Medical Press, 2013.
Cita MLA (8a ed.)MA, Singer, et al. Comparing Bevacizumab and Ranibizumab for Initial Reduction of Central Macular Thickness in Patients with Retinal Vein Occlusions. Dove Medical Press, 2013.
Precaución: Estas citas no son 100% exactas.